Back to top
more

SeaSpine Holdings Corporation (SPNE)

(Delayed Data from NSDQ)

$15.36 USD

15.36
60,781

+0.73 (4.99%)

Updated May 3, 2019 04:00 PM ET

After-Market: $15.40 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -40% and 0.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

SeaSpine (SPNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -8.57% and 3.64%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SARTORIUS (SARTF) Surpasses Q2 Earnings and Revenue Estimates

SARTORIUS (SARTF) delivered earnings and revenue surprises of 6.56% and 6.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -28.57% and 3.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Will SeaSpine Holdings (SPNE) Report Negative Earnings Next Week? What You Should Know

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine (SPNE) Moves 5.8% Higher: Will This Strength Last?

SeaSpine (SPNE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SeaSpine Holdings (SPNE) Reports Q4 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -44.44% and 1.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -29.03% and 0.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Lag Estimates

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -20% and 6.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Artivion (AORT) Reports Break-Even Earnings for Q4

Artivion (AORT) delivered earnings and revenue surprises of 100% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

SeaSpine (SPNE) Enhances ACDF Procedure With Admiral ACP System

SeaSpine's (SPNE) next-generation Admiral ACP System covers the largest segment in the estimated $1.30-billion cervical spine surgery market.

SeaSpine Holdings (SPNE) Reports Q3 Loss, Lags Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -54.84% and -3.46%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

5 Stocks to Deflect Delta Variant Curveball From Orthopedic Space

OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.

SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of 2.86% and 2.94%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Will SeaSpine Holdings (SPNE) Report Negative Q2 Earnings? What You Should Know

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Debanjana Dey headshot

Orthopedic Space Gains Momentum in 2021: 5 Stocks in Focus

Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.

SeaSpine (SPNE) Surges 13.2%: Is This an Indication of Further Gains?

SeaSpine (SPNE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

SeaSpine Holdings (SPNE) Reports Q4 Loss, Misses Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -42.31% and -2.16%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Will SeaSpine Holdings (SPNE) Report Negative Q4 Earnings? What You Should Know

SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of 20.00% and 0.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for GrowGeneration's (GRWG) Q3 Earnings?

GrowGeneration's (GRWG) third-quarter results are likely to reflect ongoing momentum in retail and online sales.

Aurora Cannabis (ACB) to Post Q1 Earnings: What's in Store?

Aurora Cannabis' (ACB) fiscal first-quarter results are likely to reflect solid prospects in the Canadian market.

Zimmer Biomet (ZBH) to Report Q3 Earnings: What's in Store?

Zimmer Biomet's (ZBH) Dental product volumes are expected to have declined significantly in the third quarter due to the extremely elective nature of the products.